US FDA Alerts Healthcare Professionals
Not To Share Insulin Pens & Cartridges
The US Food and Drug Administration issued
an alert to health care professionals reminding them that
single-patient insulin pens and insulin cartridges should not be used
to administer medication to multiple patients due to the potential
risk of transmitting blood-borne pathogens such as HIV and the
hepatitis viruses.
New Study Reconfirms Long-Term Strength Of
Biodesign Hernia Graft
A five-year study confirms the long-term
strength and durability of the Biodesign Hernia Graft, Cook Medical, a
world leader in advanced tissue repair, announced.
The study, the largest published series
with the longest follow-up time for a biologic mesh used in hernia
repair, demonstrated that the Biodesign Hernia Graft possesses the
clinically important strength of non-absorbable mesh, while providing
the benefit of decreased infection complications of absorbable mesh.
Boston Scientific Launches iCross
Coronary Imaging Catheter
Boston Scientific Corporation has launch
of its iCross Coronary Imaging Catheter, a product designed to improve
the deliverability of the company's market-leading intravascular
ultrasound (IVUS) technology, the iLab Ultrasound Imaging System. IVUS
technology enables physicians to see detailed images inside the heart
and coronary arteries. The company said the iCross Catheter would be
available immediately in the United States.
Australian Medical Devices Cos Keen To
Enter Indian Market
The medical devices industry in Australia
is set to explore the Indian market on a big scale by entering into
distribution arrangements with local companies and also taking up
manufacturing at a later stage.
DCGI Office Confuses Exporters Over
Issuance Of WHO-GMP Certificate
Utter confusion and lack of coordination
seem to prevail in the office of DCGI over the issuance of WHO-GMP
certificates for the exporters. While DCGI Dr Surinder Singh
categorically stated some days ago that there is no move to withdraw
WHO-GMP certification or replacing it with certificate of
pharmaceutical products (COPP), his North Zone office issued a
circular asking the state drugs controllers of North Zone to withdraw
the WHO-GMP Certificate issued by them.
Centre Clears DBT's Proposal To Set Up
National Institute Of Biomedical Genomics
The Centre has approved the Department of
Biotechnology (DBT)'s proposal to establish a National Institute of
Biomedical Genomics (NIBMG) at Kalyani near Kolkata in West Bengal.
Conceived under the National Biotechnology Development Strategy, the
institute will provide basic research evidence using biomedical
genomic approaches for betterment of public health programmes and
services. The Institute will be an autonomous body under the
administrative control of the DBT.
Medical Technology Industry Should Unite
To Leverage Growth Potential: Experts
The Indian medical devices industry which
is growing at the rate of around 50 per cent per annum has immense
opportunities to leverage in the near future, provided the
stakeholders and the government meeting the existing challenges in
unison, according to healthcare industry experts.
Pharmexcil To Set Up Panels For Various
Export Segments, Plans Outsourcing Expertise
In an effort to further improve the
services to ensure service to all the sectors of the Council, the
Pharmaceutical Export Promotion Council (Pharmexcil) has decided to
set up separate panels of experts for various segments related to
pharmaceutical exports.
Separate Norms For Medical Devices Soon
The government has decided to bring
separate quality guidelines for medical devices such as stents,
catheters, orthopaedic implants and heart valves by end of May. The
guidelines would make it mandatory for both domestic as well as global
medical device makers such as Siemens, Phillips, General Electric (GE)
and LG Electronics to get their products certified by notified bodies
like ISO and Bureau of Indian Standards (BIS) before selling them in
the Indian market. It would also classify medical devices based on the
risks involved. |